Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FEBUXOSTAT
- Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
- A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients
- A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Febuxostat on the Pharmacokinetics of Methotrexate in Healthy Subjects
- Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia
- Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
- An Innovative Chinese Herbal Formula for the Treatment of Gout
- Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients
- A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults
- To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout
- Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
- Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
- A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout
- Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout
- Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
- Role of Uralyt-U in Patients With Hyperuricemia
- Study of Verinurad in Heart Failure With Preserved Ejection Fraction
- A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia
- The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia
- Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients
- Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy
- Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms
- A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia
- Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions
- Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
- Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)
- Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults
- Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
- Effect of Hyperuricaemia on Chronic Renal Disease
- Uric Acid Effects on Endothelium and Oxydative Stress
- Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
- The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF)
- A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA
- A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
- Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients
- Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients
- The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout
- Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
- Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
- Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.
- Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion
- Zurig (Febuxostat) 40mg Efficacy and Safety Trial
- CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
- Phase 1, Febuxostat XR Relative Bioavailability Study
- Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout
- Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule
- Food Effect Study of Febuxostat XR in Healthy Participants
- The Effect of Uric Acid Lowering in Type 1 Diabetes
- Compare the Renal Protective Effects of Febuxostat and Benzbromarone
- A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients
- A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
- the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia
- Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
- RDEA3170 and Febuxostat Combination Study in Gout Subjects
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
- Safety and Efficacy of Oral Febuxostat in Subjects With Gout
- Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels
- Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy
- RDEA3170 and Febuxostat Drug Interaction Study
- Lesinurad and Febuxostat Combination Extension Study in Gout
- The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina
- A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
- Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies
- A Proof-of-Concept Study of AC-201 to Prevent Gout Flares
- The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
- Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
- Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers
- Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina
- Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
- Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
- Effect of Febuxostat on Blood Pressure
- Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
- Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
- Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
- Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
- An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
- Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
- Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
- Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
- Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones
- Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia
- Phase III Trial of Febuxostat in Korea Gout Patients
- Efficacy and Safety of Oral Febuxostat in Participants With Gout
- Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010
- Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
- Long-Term Safety of Febuxostat in Subjects With Gout.
- Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
- Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
Clinical trials list
click for details